Interleukin-33/Suppression of Tumorigenicity 2 (IL-33/ST2) Axis in Idiopathic Inflammatory Myopathies and Its Association With Laboratory and Clinical Parameters: A Pilot Study

Rheumatology International - Germany
doi 10.1007/s00296-020-04554-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC